Although evidence suggests antibody responses following COVID-19 vaccination provide better neutralization of some circulating coronavirus variants than does natural infection, few real-world epidemiologic studies exist to support the benefit of vaccination for previously infected persons, wrote the U.S. CDC’s Morbidity and Mortality Weekly Report issued on August 6, 2021.
The natural immunity Vs. COVID-19 vaccine-generated immunity debate continues after about eight months because it isn’t always clear how long any virus immunity persists.
COVID-19 Natural Immunity Debate Continues
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Aug. 2 to 6, 2021. This …
Many Parents Do Not Plan to Vaccinate Youngest Child for COVID-19
49.4 percent of parents surveyed in one study and 61.9 percent in second study intend to vaccinate youngest
White House Outlines Effort to Vaccinate Young as Schools Start to Reopen
Push will include enlisting pediatricians to make COVID-19 vaccination part of back-to-school sports physicals
White House Considering Stronger Measures to Boost COVID-19 Vaccinations
Administration looking at using federal regulatory powers and the threat of withholding federal funds from institutions to increase vaccination rates
All Health Care, Long-Term Care Workers in California Must Get COVID-19 Shots
Order issued as the most populous state in the country struggles to slow infections caused by the highly contagious delta variant
Novavax Seeks Approval for Vaccine in Needy Countries First
Novavax vaccine is easier to store and transport than some other vaccines
Antibody Levels High With COVID-19 Vaccination for Previously Infected
Antibody levels higher in previously infected versus infection-naive after one dose of BNT162b2 vaccine